Recent news on Precedex

Abbott pulls out of developing Orion's Simdax in the USA  -  Apr 26, 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway,

Abbott pulls out of developing Orion's Simdax in the USA  -  26 Apr 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway,

ORION: Orion Group Interim Report 1-3/2007  -  Apr 25, 2007
Kauppalehti (press release),The clinical Phase 3 is being started in May with dexmedetomidine (Precedex®) as a long-term infusion for the sedation of patients in intensive care,

Portion of Orion profits may go towards new Simdax study  -  Feb 7, 2007
Pharma Times (subscription),A Phase III study looking at Precedex (dexmedetomidine) as a long-term infusion for the sedation of patients in intensive care is also underway.

Orion Oyj: Bulletin of orion corporation financial statements for ...  -  Feb 6, 2007
Kauppalehti (press release),The clinical Phase 3 is being started with dexmedetomidine (Precedex®) as a long-term infusion for the sedation of patients in intensive care,

CONSCIOUS SEDATION  -  Dec 1, 2006
EndoNurse,And, she continues, “I have been saying for a few years now that we may see Precedex move into the moderate sedation arena. I saw a research article the

Dexmedetomidine Effective for Procedural Sedation in Children With ...  Oct 11, 2006
ATLANTA, GA -- October 11, 2006 -- Successful and uneventful sedation using dexmedetomidine (Precedex) is possible for children with pervasive developmental ... -DG News CONSCIOUS SEDATION  -  Dec 1, 2006
EndoNurse,And, she continues, “I have been saying for a few years now that we may see Precedex move into the moderate sedation arena. I saw a research article the

Orion Oyj: Orion group financial review 1-6/2006  Aug 7, 2006
A Phase 2 study is underway in Switzerland and Finland with dexmedetomidine (Precedex®) as a long-term infusion for the sedation of patients in intensive care ... -Kauppalehti



Orion Oyj: Orion group interim report 1-3/2006  May 8, 2006
Fareston (breast cancer) 3.7 3.9 -4.1 % 10.7 Calcimagon (osteoporosis) 3.6 2.8 +26.4 % 10.2 Enanton (prostate cancer) 3.4 3.3 +2.8 % 13.6 Precedex (sedative in ... - Kauppalehti

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional